Teva Initiates Voluntary Nationwide Recall of Specific Lots of FENTANYL Buccal Tablets CII Due to a Labeling Error

Medication SafetyEducators and caregiversHealthcare ProfessionalOpioid epidemicSubstance use disorderPublic health
Written By Denise Kolakowski

The main safety concern is a potential for incomplete information needed by health care providers and patients regarding safe use of the product.

Learn more
Denise Kolakowski
Previous

FDA warns consumers to not purchase or use Nose Slap and Soul Slap products marketed for alertness and energy boosting
Next

TruVision Health Recalls Dietary Supplement Products Because of Possible Health Risk